Dossiers, industry reports and further studies. 
Exclusive Statista studies on market-relevant topics: 
About This Statistic
This statistic shows the top 20 pharmaceutical corporations by revenue in the United States in 2015. Pharmaceutical corporation Pfizer generated some 19.6 billion U.S. dollars in revenue within the United States.
- Health & Pharmaceuticals ›
- Pharmaceutical Products & Market ›
Pharmaceutical corporations by U.S. revenue 2015
Top 20 pharmaceutical corporations by U.S. revenue in 2015 (in billion U.S. dollars)*
Exclusive content
Exclusive Premium statistic
Get a Premium Account for unrestrained access.
Benefits of our Premium membership:
- Access to all Premium statistics
- Download as XLS, PNG and PDF
- Detailed source and background information
Premium Account
$49 per month*
(billed annually)
(billed annually)
Loading statistic...
| Revenue in billion U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
© Statista 2017
Show further information
Complete Source Details
Special Functions
Download as ...
Graphic (PNG)
Excel (XLS)
PowerPoint (PPT)
PDF
Options
Settings
Print
Research Alerts
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
+Top 10 biotech and pharmaceutical companies based on market value 2016
+Top 50 pharmaceutical companies - Rx sales and R&D spending 2016
+Novartis' top drugs based on revenue 2016
+Top cancer drugs based on revenue worldwide 2015
+Novartis' expenditure on research and development 2004-2016
+Novartis' revenue by region 2016
Statista Accounts: Access All Statistics. Starting from $588 / Year
Statistics on "Novartis"
- Global positioning
The most important statistics
- Top 10 biotech and pharmaceutical companies worldwide based on market value in 2016 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market value 2016
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2016 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2016
- Top 20 pharmaceutical corporations by U.S. revenue in 2015 (in billion U.S. dollars)*Pharmaceutical corporations by U.S. revenue 2015
- Top 10 cancer drugs worldwide by revenue in 2015 (in billion U.S. dollars)Top cancer drugs based on revenue worldwide 2015
- Company overview
The most important statistics
- Novartis AG's total revenue from 2007 to 2016 (in billion U.S. dollars)Novartis' revenue 2007-2016
- Novartis AG's net income from 2007 to 2016 (in billion U.S. dollars)Novartis' net income 2007-2016
- Dividends paid by Novartis AG from 2009 to 2016 (in billion U.S. dollars)Dividends paid by Novartis AG 2009-2016
- Total number of Novartis AG's full-time employees from 2009 to 2016*Novartis' number of full-time employees 2009-2016
- Revenue distribution
The most important statistics
- Novartis AG's revenue from 2012 to 2016, by segment (in billion U.S. dollars)Novartis revenue 2012-2016 by segment
- Novartis AG's revenue in 2016, by region (in million U.S. dollars)Novartis' revenue by region 2016
- Novartis AG's top 10 drugs based on revenue in 2016 (in million U.S. dollars)Novartis' top drugs based on revenue 2016
- Research and development
The most important statistics
- Novartis AG's expenditure on research and development from 2004 to 2016 (in billion U.S. dollars)Novartis' expenditure on research and development 2004-2016
- Novartis AG's R&D expenditure as a percent of revenue from 2004 to 2016Novartis' R&D expenditure as a percent of revenue 2004-2016
- Novartis AG's spending on research and development by division in 2016 (in billion U.S. dollars)Novartis' spending on research and development by division 2016
- Contribution of Novartis AG's growth products to pharmaceutical revenue from 2009 to 2016*Novartis AG's growth products as percent of pharma revenue 2009-2016
- Miscellaneous
The most important statistics
- Patients reached by products of Novartis AG from 2009 to 2016 (in millions)Patients reached by Novartis AG's products 2009-2016
- Novartis advertising spending in the United States from 2012 to 2016 (in million U.S. dollars)Novartis: ad spend in the U.S. 2012-2016
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
U.S. pharmaceutical industry
- 110 page/s
- English
- pptx
- Detailed references
Everything On "U.S. pharmaceutical industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
Statista for Your Company: The Research and Analysis Tool
- Product Film
- Statistics
- Downloads
Our Premium Statistics - facts for your business
Currently, Statista provides more than 1 million statistics. 93 percent (all Premium content) are exclusively accessible via our professional accounts.
Unlimited access
As a Statista Premium customer, you receive unlimited access to all statistics at all times. Including downloads of data in the most common formats (XLS, PDF & PNG). Create relevant and significant statistics in no time.
You are in good company
Google
Samsung
Unilever
Procter and Gamble
Adobe
Telekom
PayPal
Otto
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Pharmaceutical corporations by U.S. market share 2015
- Pharmaceutical corporations by U.S. sales 2010
- Top 50 pharmaceutical companies by prescription sales a...
- Prescription drug advertising in the U.S. 2010-2014
- Most advertised drugs in the U.S. in 2014, by ad spendi...
- Quickness of financial reporting of selected pharmaceut...
- Business risks at selected pharmaceutical companies 201...
- Lease expenses of selected U.S. pharmaceutical companie...
- GAAP earnings - adjustments of selected U.S. pharmaceut...
- Top known pharma companies by Americans 2017
- Leading pharmaceutical companies: world market share 20...
- Top 10 - pharmaceutical companies based on revenue in 2...
- Journal spend of respiratory products in the U.S. 2015
- Top known pharma companies by Americans and gender 2017
- Americans' preferred pharma companies for drug purchase...
- United Kingdom (UK): pharmaceutical products export val...
- United Kingdom (UK): pharmaceutical products import val...
- United Kingdom (UK): pharmaceutical products export val...
- United Kingdom (UK): pharmaceutical products export val...
- United Kingdom (UK): pharmaceutical products import val...
Studies
- Valeant Pharmaceuticals - Annual Report 2016
- Generic Pharmaceutical Industry Yearbook 2016
- Top 200 Products in the US Market by Sales, 2009
- Valeant Pharmaceuticals - Form 10-K 2015
- Novartis
- Deal Capsule: Transactions in Chemicals & Pharmaceuticals - Janua...
- Deal Capsule: Transactions in Chemicals & Pharmaceuticals - April...
- Pharmaceutical & Biotech Sales Analysis by Country - Top Drugs, T...
- Pharmaceutical trends in Europe
- Sharing knowledge on topical issues in the Pharmaceuticals indust...
- Deal Capsule: Transactions in Chemicals & Pharmaceuticals - July...
- Great Expectations: Why Pharma Companies Can’t Ignore Patient Ser...
- Johnson & Johnson
- The PharmExec 50 (2012)
- Deal Capsule: Transactions in Chemicals & Pharmaceuticals - July...
Our Business Solutions: Save Time and Money
only
$588*
per yearYour advantages
- Full access to all our statistics
- Download as XLS, PDF & PNG
- Relevant data: complete source information
All functions of our platform illustrated face-to-face
- Learn how Statista supports your company
- Extensive tour across the whole portal
- Personal guidance by our support team
The knowledge database for your company
- All functions of the Premium Account
- Access to dossiers, forecasts and studies
- Access to our international database
- Publishing rights and other exclusive functions
* All products require an annual contract.
Prices do not include sales tax
(New York residents only).
Exclusive Premium functionality
Register in seconds and access exclusive features.
- Full access:
To this and over 1 million additional datasets - Save Time:
Downloads allow integration with your project - Valid data:
Access to all sources and background information
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.